Clinical Trial Update: A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olaparib given before surgery and chemotherapy in ovarian, primary peritoneal, and fallopian tube cancers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: UNKNOWN